Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells

BACKGROUND: Specific immune response is a hallmark of cancer immunotherapy and shared tumor-associated antigens (TAAs) are important targets. Recent advances using combined cellular therapy against multiple TAAs renewed the interest in this class of antigens. Our study aims to determine the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thelen, Martin, Keller, Diandra, Lehmann, Jonas, Wennhold, Kerstin, Weitz, Hendrik, Bauer, Eugen, Gathof, Birgit, Brüggemann, Monika, Kotrova, Michaela, Quaas, Alexander, Mallmann, Christoph, Chon, Seung-Hun, Hillmer, Axel M, Bruns, Christiane, von Bergwelt-Baildon, Michael, Garcia-Marquez, Maria Alejandra, Schlößer, Hans Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743382/
https://www.ncbi.nlm.nih.gov/pubmed/36600602
http://dx.doi.org/10.1136/jitc-2022-005200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743382/
https://www.ncbi.nlm.nih.gov/pubmed/36600602
http://dx.doi.org/10.1136/jitc-2022-005200

Ejemplares similares